![]() |
![]() |
![]() |
![]() |
3-LDV | ENHANCED DELIVERY OF NANOMEDICINE TO KIDNEY GRAFT ENDOTHELIAL CELLS DURING EX VIVO PERFUSION | Claire ALBERT | ![]() |
![]() |
|||
3-OP | CRISPR-CAS9 HLA-DELETED GLOMERULAR ENDOTHELIAL CELLS AS A TOOL TO DETECT PATHOGENIC NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS | Baptiste Lamarthée | ![]() |
![]() |
|||
6-OP | TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODY-MEDIATED REJECTION | Gesa Tiller | ![]() |
![]() |
|||
7-OP | CD56DIM CD16BRIGHT NK CELLS DURING ANTIBODY-MEDIATED REJECTION DISPLAY INCREASED PROLIFERATION, ACTIVATION AND TYPE-1 INFLAMMATORY CYTOTOXIC PROFILES | Elodie Bailly | ![]() |
![]() |
|||
9-OP | WATERLOW SCORE ON ADMISSION AND POST-SURGERY RISK OF PROLONGED LENGTH OF STAY, EMERGENCY READMISSION AND MORTALITY RISK | Anna Brotherton | ![]() |
![]() |
|||
10-OP | FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Evelien Quint | ![]() |
![]() |
|||
11-OP | ASSESSING RISK FACTORS OF NON-ADHERENCE AND POST-TRANSPLANT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS | Kateryna Maksyutynska | ![]() |
![]() |
|||
12-OP | IMPACT OF THE COVID-19 PANDEMIC ON DAILY LIVES, EMOTIONS AND BEHAVIOURS OF KIDNEY TRANSPLANT RECIPIENTS | Regina Van Zanten | ![]() |
![]() |
|||
13-OP | SOCIAL DISTRESS AND HEALTH-RELATED QUALITY OF LIFE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Noor Al Kaabi | ![]() |
![]() |
|||
14-OP | RENAL TRANSPLANT OUTCOMES IN YOUNG ADULTS BEFORE AND AFTER THE INTRODUCTION OF A YOUNG ADULT SERVICE | Laura Baines | ![]() |
![]() |
|||
15-OP | SUPPORTING TEENAGE AND YOUNG ADULT TRANSPLANT RECIPIENTS DURING COVID-19 PANDEMIC USING A SOCIAL MEDIA PATIENT GROUP | Daley Cross | ![]() |
![]() |
|||
16-OP | SHORT- AND LONG-TERM PREGNANCY OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN THE NETHERLANDS | Jildau Meinderts | ![]() |
![]() |
|||
17-OP | FATIGUE AMONG HEART RECIPIENTS- A BARRIER TO SELF-EFFICACY? | Matilda Almgren | ![]() |
![]() |
|||
18-OP | SYMPTOM OCCURRENCE AND DISTRESS AFTER HEART TRANSPLANTATION - A NATIONWIDE CROSS-SECTIONAL COHORT STUDY. | Marita Dalvindt | ![]() |
![]() |
|||
19-OP | RECOVERY AND SELF-EFFICACY AFTER HEART TRANSPLANTATION- IMPORTANT ASPECTS OF SELF-MANAGEMENT | Matilda Almgren | ![]() |
![]() |
|||
20-OP | THE MEANING OF SURVIVING THREE YEARS AFTER A HEART TRANSPLANT - A TRANSITION FROM UNCERTAINTY TO ACCEPTANCE THROUGH ADAPTATION | Anna Forsberg | ![]() |
![]() |
|||
21-OP | FATIGUE, SELF-EFFICACY AND RECOVERY 1-5 YEARS AFTER LUNG TRANSPLANTATION | Annette Lennerling | ![]() |
![]() |
|||
22-OP | ADAPTATION AFTER LUNG TRANSPLANTATION UP TO THREE YEARS AFTER TRANSPLANTATION. | Martina Lundmark | ![]() |
![]() |
|||
23-OP | OUTCOME OF LIVER TRANSPLANTATION FOR NON-HCC MALIGNANCIES – A COLLABORATIVE TRANSPLANT STUDY REPORT | Philipp Houben | ![]() |
![]() |
|||
25-OP | DIFFERENT PATTERNS OF RECURRENCE AFTER LIVER RESECTION AND TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS | Jorgelina Coppa | ![]() |
![]() |
|||
26-OP | LONG TERM OUTCOMES AFTER LIVER TRANSPLANTATION VERSUS RESECTION FOR MILAN-IN NEUROENDOCRINE TUMOR LIVER METASTASES | Marianna Maspero | ![]() |
![]() |
|||
27-OP | UNRESECTABLE GASTROINTESTINAL STROMAL TUMOR (GIST) LIVER METASTASES AS A NEW INDICATION FOR LIVER TRANSPLANTATION. HAS ITS TIME ARRIVED? | Felipe Alconchel | ![]() |
![]() |
|||
31-OP | EVOLUTION OF PATIENTS WITH DEVASTATING BRAIN INJURY ADMITTED IN INTENSIVE CARE UNIT FOR INTENSIVE CARE TO FACILITATE ORGAN DONATION | Alicia Perez | ![]() |
![]() |
|||
32-OP | PERCEIVED AND VERIFIED CANCER HISTORY IN POTENTIAL SOLID ORGAN DONORS: AN AUSTRALIAN COHORT STUDY | James Hedley | ![]() |
![]() |
|||
34-OP | THE ROLE OF THE SURGICAL CARE PRACTITIONER IN ORGAN RETRIEVAL: A SINGLE-CENTRE EXPERIENCE | Francesco Abbadessa | ![]() |
![]() |
|||
35-OP | ASSESSMENT OF DONOR-RECIPIENT SIZE MISMATCH BASED ON BODY SURFACE AREA INDEX AND ITS IMPLICATIONS ON OUTCOMES OF DECEASED-DONOR LIVER TRANSPLANTS | Ioannis D. Kostakis | ![]() |
![]() |
|||
38-OP | FACING THE CHALLENGE: TRANSPLANT ACCESS FOR THE HIGHEST SENSITIZED PATIENTS (CPRA=100%). THE SPANISH EXPERIENCE | Maria O Valentin | ![]() |
![]() |
|||
39-OP | IMPACT OF INHIBITION OF PCSK-9 AMONG RENAL TRANSPLANT RECIPIENTS WITH HIGH CARDIOVASCULAR RISK | Osama Gheith | ![]() |
![]() |
|||
40-OP | IMPACT OF FULL CORRECTION OF POST-TRANSPLANT ANEMIA ON CARDIOVASCULAR SYSTEM IN RENAL TRANSPLANT RECIPIENTS RECEIVING ESA: PROSPECTIVE RCT | Ayman Maher Nagib | ![]() |
![]() |
|||
41-OP | IS ERYTHROCYTOSIS MORE FREQUENT AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION?: A SINGLE-CENTER EXPERIENCE | Marina Reis | ![]() |
![]() |
|||
42-OP | COMPARING SURVIVAL OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS WITH PRE-EXISTING DIABETES VERSUS THOSE WHO DEVELOP POST-TRANSPLANTATION DIABETES | Azm Hussain | ![]() |
![]() |
|||
43-OP | OUTCOMES OF SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES | Tarek Mahmoud | ![]() |
![]() |
|||
44-OP | HLA ALLELES CW12 AND DQ4 IN KIDNEY TRANSPLANT RECIPIENTS ARE INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANTATION DIABETES | Azm Hussain | ![]() |
![]() |
|||
45-OP | SEMAGLUTIDE IS A SAFE AND EFFECTIVE TREATMENT IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POST-TRANSPLANT DIABETES MELLITUS | Maarten Tushuizen | ![]() |
![]() |
|||
46-OP | DETERMINATS OF THE APPERANANCE OF POST TRANSPLANT DIABETES MELLITUS AFTER KINDEY TRASNAPLANTION | Maria Smyrli | ![]() |
![]() |
|||
47-OP | AMPUTATION AND ULCERATION IN TYPE-1 DIABETIC PATIENTS UNDERGOING SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION: A SYSTEMATIC REVIEW | Jineel Raythatha | ![]() |
![]() |
|||
48-OP | EVEROLIMUS, GLUCOSE METABOLISM, AND ANTI- VISCERAL OBESITY EFFECT IN KIDNEY TRANSPLANT CANDIDATES | Mikiko Yoshikawa | ![]() |
![]() |
|||
49-OP | OUTCOMES OF LIVER TRANSPLANTS FOR NASH FROM A LARGE SINGLE INSTITUTIONAL COHORT | Aamir Nawaz | ![]() |
![]() |
|||
50-OP | VARIATIONS IN TM6SF2 RS58542926, PCSK9 RS505151 AND PCSK7 RS2277287 WITH THE RISK OF HEPATIC STEATOSIS AFTER LIVER TRANSPLANTATION | Ahad Eshraghian | ![]() |
![]() |
|||
51-OP | IMPACT OF ELECTIVE LIGATION OF A PATENT ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS ON BLOOD PRESSURE AND SERUM LEVELS OF CARDIAC BIOMARKERS | Gregoire Masson | ![]() |
![]() |
|||
52-OP | POSITIVE IMPACT OF KIDNEY TRANSPLANTATION ON OLFACTORY ABILITY: RESULTS OF A CROSS-SECTIONAL CASE CONTROL STUDY. | Chiara Caletti | ![]() |
![]() |
|||
53-OP | IMPACT OF FCGR3A POLYMORPHISMS ON AMR OUTCOME AND IVIG RESPONSE IN KIDNEY TRANSPLANT RECIPIENTS | Alice Koenig | ![]() |
![]() |
|||
54-OP | THE FCGR3A-158 V/V-GENOTYPE IS ASSOCIATED WITH DECREASED SURVIVAL OF RENAL ALLOGRAFTS WITH CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION | Nicolle Litjens | ![]() |
![]() |
|||
55-OP | PREFORMED T-CELL ALLOIMMUNITY AND HLA EPLET MISMATCH TO GUIDE IMMUNOSUPPRESSION MINIMIZATION WITH TACROLIMUS MONOTHERAPY IN KIDNEY TRANSPLANTATION. | Maria Meneghini | ![]() |
![]() |
|||
56-OP | HLA EPITOPE MISMATCHES IN KIDNEY TRANSPLANT RECIPIENTS WITH HISTOLOGICAL ANTIBODY-MEDIATED REJECTION WITH AND WITHOUT HLA DONOR-SPECIFIC ANTIBODIES | Laura Llinàs-Mallol | ![]() |
![]() |
|||
57-OP | UNSUPERVISED MACHINE LEARNING IDENTIFIES FAST AND SLOW MODULATION OF DSA DYNAMICS FOLLOWING HLA- INCOMPATIBLE TRANSPLANTATION – 5 YEAR OUTCOMES. | Sunil Daga | ![]() |
![]() |
|||
58-OP | MYELOID-DERIVED SUPPRESSOR CELLS IN KIDNEY TRANSPLANT RECIPIENTS AND THE EFFECT OF MAINTENANCE IMMUNOTHERAPY | Maria Iglesias Escudero | ![]() |
![]() |
|||
59-OP | CLINICAL VALUE OF THE USE OF COMPLETE HIGH RESOLUTION HLA TYPING FOR THE DEFINITION OF DNDSA AFTER KIDNEY TRANSPLANTATION | Maria Meneghini | ![]() |
![]() |
|||
60-OP | DONOR-SPECIFIC ELISPOT ASSAY FOR PREDICTING ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Suwasin Udomkarnjananun | ![]() |
![]() |
|||
61-OP | HLA AND NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTOLOGICAL PICTURE OF ANTIBODY-MEDIATED REJECTION | Laura Llinàs-Mallol | ![]() |
![]() |
|||
62-OP | DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AND ABMR IN RENAL TRANSPLANT PATIENTS DEPENDS ON CYP3A5 GENOTYPE | Justa Friebus-Kardash | ![]() |
![]() |
|||
63-OP | EVOLUTION OF HUMORAL LESIONS ON CONTROL BIOPSY STRATIFIES THE RISK FOR RENAL GRAFT LOSS AFTER ANTIBODY-MEDIATED REJECTION TREATMENT | Antonin Bouchet | ![]() |
![]() |
|||
64-OP | CHALLENGING EARLY CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION AFTER SUCCESSFUL DESENSITIZATION FOR CDC-CROSSMATCH-POSITIVE KIDNEY TRANSPLANTION. | Annelies De Weerd | ![]() |
![]() |
|||
65-OP | TEMRA CD8 T CELLS FROM KIDNEY TRANSPLANT RECIPIENTS EXHIBIT ENHANCED PURINERGIC P2X4 RECEPTOR-DEPENDENT PROINFLAMMATORY AND MIGRATORY RESPONSES | Nicolas Degauque | ![]() |
![]() |
|||
66-OP | GRANZYME B POSITIVE B CELLS ENRICH REGULATORY T CELL COMPARTMENT AND INDUCE INHIBITION OF EFFECTOR CD4+ CD25- T CELL RESPONSE. | Nicolas Sailliet | ![]() |
![]() |
|||
67-OP | THE IMPACT OF DONOR AND RECIPIENT SIZE IN PAEDIATRIC RENAL TRANSPLANTATION | Ioannis D. Kostakis | ![]() |
![]() |
|||
68-OP | UK CONSENSUS ON SURGICAL TECHNIQUES IN PAEDIATRIC RENAL TRANSPLANT | John Fallon | ![]() |
![]() |
|||
69-OP | IMPACT OF VASCULAR ANOMALIES ON SURGICAL COMPLICATIONS AND OUTCOME IN PEDIATRIC KIDNEY TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER ANALYSIS. | Gionata Spagnoletti | ![]() |
![]() |
|||
70-OP | FINAL HEIGHT OF CHILDREN OVER 12 YEARS INITIATED ON A STEROID MINIMISATION IMMUNOSUPPRESSIVE REGIMEN FOLLOWING KIDNEY TRANSPLANTATION | Demetria Theodorou | ![]() |
![]() |
|||
71-OP | IMPACT OF DONOR HUMAN LEUKOCYTE ANTIGEN SPECIFIC ANTIBODIES DETECTED IN PEDIATRIC KIDNEY TRANSPLANT PATIENTS WITH STABLE OR DECLINED GRAFT FUNCTION | Asimina Fylaktou | ![]() |
![]() |
|||
73-OP | STANDARDISATION OF IMMUNOSUPPRESSIVE AND ANTI-INFECTIVE DRUG REGIMENS IN UK PAEDIATRIC RENAL TRANSPLANTATION: THE HARMONISATION PROGRAMME | Stephen D Marks | ![]() |
![]() |
|||
74-OP | KIDNEY TRANSPLANTED CHILDREN NOT RESPONDING TO ANTI-REJECTION TREATMENT: HOW TO IMPROVE THE OUTCOME | Irene Alberici | ![]() |
![]() |
|||
77-OP | LUNG TRANSPLANT FOR PULMONARY FIBROSIS; SMALLER DONOR LUNGS IMPACT SURVIVAL | Gillian Hardman | ![]() |
![]() |
|||
81-OP | DONOR LYMPHOCYTES IN PERIPHERAL BLOOD OF PATIENTS AFTER LUNG TRANSPLANTATION COMPRISE HIGH FREQUENCIES OF KIR-POSITIVE T AND NK CELL SUBSETS | Jenny Kuehne | ![]() |
![]() |
|||
82-OP | MIR-339 AND GALECTIN-3: DIAGNOSTIC VALUE IN PATIENTS WITH AIRWAY OBSTRUCTION AFTER LUNG TRANSPLANTATION | Olga Gichkun | ![]() |
![]() |
|||
86-OP | MONITORING OF ANTIVIRAL IMMUNE RESPONSE AS AN INDICATOR OF IMMUNOSUPPRESSION INTENSITY AND OUTCOME AFTER KIDNEY TRANSPLANTATION: THE VIRENO STUDY | Veronica Di Cristanziano | ![]() |
![]() |
|||
87-OP | LUMINAL ACTIVATION OF COMPLEMENT WITH APICAL DEPOSITION OF C3DG AND C5B-9 IN THE PROXIMAL TUBULES IN KIDNEY TRANSPLANT RECIPIENTS | Gustaf Isaksson | ![]() |
![]() |
|||
88-OP | THE UPTAKE OF THE PET RADIOTRACER 18-FLUORODEOXYGLUCOSE BY THE RENAL ALLOGRAFT CORRELATES WITH THE ACUTE BANFF SCORES OF CORTEX INFLAMMATION | Francois Jouret | ![]() |
![]() |
|||
91-OP | OBSERVATIONS ON 24-HOUR EX SITU NORMOTHERMIC LIVER PERFUSION | Amelia Hessheimer | ![]() |
![]() |
|||
95-OP | ASSOCIATION OF PROCUREMENT TIME WITH SHORT- AND LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION | Verner Eerola | ![]() |
![]() |
|||
96-OP | HEPATITIS B OCCULT INFECTION IN DECEASED LIVER DONORS: LONG TERM POST TRANSPLANT CLINICAL EVALUATION. | Davide Cussa | ![]() |
![]() |
|||
97-OP | PROPOSAL AND VALIDATION OF A LIVER GRAFT DISCARD SCORE FOR LIVER TRANSPLANTATION: A MULTICENTRE ITALIAN STUDY | Fabio Melandro | ![]() |
![]() |
|||
98-OP | EXTENDED CRITERIA DONORS IN LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Francesco Giovinazzo | ![]() |
![]() |
|||
99-OP | DONATION AFTER CIRCULATORY DEATH LIVERS CAN BE SAFELY USED FOR TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING PORTAL VEIN THROMBOSIS | Willemijn Van Der Plas | ![]() |
![]() |
|||
100-OP | RISK FACTORS ASSOCIATED WITH HISTOLOGICAL INJURY TO THE DEEP PERIBILIARY GLANDS AND PERIBILIARY VASCULAR PLEXUS PRIOR TO LIVER TRANSPLANTATION | Willemijn Van Der Plas | ![]() |
![]() |
|||
101-OP | INDICATIONS AND WAITING LIST PRIORITY FOR DECEASED DONOR LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS IN JAPAN. | Susumu Eguchi | ![]() |
![]() |
|||
102-OP | RECENT TRENDS AND INTENTION-TO-TREAT SURVIVAL OF LIVER TRANSPLANTATION FOR NONALCOHOLIC STEATOHEPATITIS:AN ITALIAN LIVER TRANSPLANT REGISTRY STUDY | Chiara Di Renzo | ![]() |
![]() |
|||
103-OP | OUTCOMES OF DONORS WITH BMI=30 FOR LIVING DONOR LIVER TRANSPLANTATION | Oya Andacoglu | ![]() |
![]() |
|||
104-OP | PERFORMANCE OF ARTIFICIAL INTELLIGENCE IN PREDICTING SURVIVAL FOLLOWING LIVER TRANSPLANTATION: STUDY USING DATA FROM THE KOREAN TRANSPLANT REGISTRY | Young-Dong Yu | ![]() |
![]() |
|||
105-OP | UPDATE ON WAITLIST MORTALITY OF YOUNG PATIENTS WITH BILIARY ATRESIA - RESULTS FROM THE EUROTRANSPLANT DATABASE | Heda Esmati | ![]() |
![]() |
|||
106-OP | LIVER TRANSPLANTATION (LT) IN HIGH-MELD (= 30) PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): SINGLE-CENTER EXPERIENCE WITH 90 CASES | Andrea Della Penna | ![]() |
![]() |
|||
107-OP | EVOLUTION OF INDICATION IN LIVER TRANSPLANTATION IN ITALY: THE CNT REGISTRY STUDY; ECALITA STUDY. ON BEHALF OF ECALITA STUDY GROUP | Tommaso Maria Manzia | ![]() |
![]() |
|||
108-OP | IMPACT EXTENDED LIVING DONOR CRITERIA FOCUSING ON DONOR SAFETY IN LIVING DONOR LIVER TRANSPLANTATION | Joodong Kim | ![]() |
![]() |
|||
109-OP | HLA-DQ DISPARITIES AND KIDNEY TRANSPLANT OUTCOME | Aleksandar Senev | ![]() |
![]() |
|||
110-OP | KIDNEY RECIPIENTS CHARACTERISTICS QUESTIONED THE DISCRIMINATIVE CAPACITIES OF KIDNEY DONOR RISK INDEX: AN EXTERNAL VALIDATION FROM A FRENCH COHORT | Anne-Hélène Querard | ![]() |
![]() |
|||
111-OP | DONOR FACTORS -FOR KIDNEYS ACCEPTED FOR TRANSPLANTATION- MARGINALLY IMPACT TRANSPLANT OUTCOMES. CONCLUSIONS FROM NATIONWIDE PAIRED OUTCOME ANALYSES | Jan Lindeman | ![]() |
![]() |
|||
112-OP | IMPACT OF ASIAN AND BLACK DONOR AND RECIPIENT ETHNICITY ON THE OUTCOMES AFTER DECEASED DONOR KIDNEY TRANSPLANTATION IN THE UNITED KINGDOM | Abdul Rahman Hakeem | ![]() |
![]() |
|||
113-OP | PREDICTING NUCLEAR RENOGRAPHY BASED SPLIT RENAL FUNCTION IN LIVING DONOR TRANSPLANTATION WITH CT BASED MEASURED SPLIT RENAL VOLUMES | Bahattin Ozkul | ![]() |
![]() |
|||
114-OP | EPITOPE DISTRIBUTION AND FEASIBILITY OF PIRCHE-II T-CELL MATCHING FOR RENAL TRANSPLANTATION IN CANADA | Karen R Sherwood | ![]() |
![]() |
|||
115-OP | ITALIAN NATIONAL KIDNEY ALLOCATION ALGORHITM (INKAA): APPLICATION AND FIRST RESULTS | Andrea Ricci | ![]() |
![]() |
|||
116-OP | THE IMPACT OF COLD ISCHAEMIA TIME ON OUTCOMES OF LIVING DONOR KIDNEY TRANSPLANTATION IN THE UK LIVING KIDNEY SHARING SCHEME | Stijn Van De Laar | ![]() |
![]() |
|||
117-OP | CLOSING THE GAP: EXAMINING WAIT LIST OUTCOMES FOR THE MOST HIGHLY SENSITIZED CANDIDATES IN THE USA ACROSS REGIONS | Miriam Manook | ![]() |
![]() |
|||
118-OP | THE REMUZZI SCORE IS A SAFE DECISION-MAKING TOOL AND UTILIZES MORE KIDNEYS FOR TRANSPLANT COMPARED TO DONOR EGFR | Annemarie Weissenbacher | ![]() |
![]() |
|||
119-OP | LONG-TERM EVOLUTION OF KIDNEY GRAFT DONATION PROCEDURES IN UNCONTROLLED DONORS AFTER CARDIAC DEATH IN THE COMMUNITY OF MADRID | Alonso Mateos-Rodriguez | ![]() |
![]() |
|||
120-OP | MODIFIED FRAILITY INDEX (MFI-11): A SIMPLE TOOL TO ACCESS FRAILTY IN OLDER KIDNEY TRANSPLANT WAITING LIST POPULATION | Mariana Sousa | ![]() |
![]() |
|||
121-OP | COMPARING OUTCOMES IN RIGHT VERSUS LEFT KIDNEY TRANSPLANTATION; A SYSTEMATIC REVIEW AND META-ANALYSIS | Caitlin Carolan | ![]() |
![]() |
|||
122-OP | ARE UNSPECIFIED KIDNEY DONORS TREATED DIFFERENTLY TO SPECIFIED KIDNEY DONORS? VIEWS OF UK TRANSPLANT PROFESSIONALS | Mira Zuchowski | ![]() |
![]() |
|||
123-OP | UK DECEASED DONATION AND TRANSPLANT ACTIVITY IN PAEDIATRICS FOR 2019 – 2020 | Chloe Brown | ![]() |
![]() |
|||
124-OP | THE END STAGE RENAL DISEASE (ESRD) IN ANORECTAL MALFORMATION (ARM) PATIENTS: RISK FACTORS AND OUTCOME. | Miriam Duci | ![]() |
![]() |
|||
125-OP | PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Reshma Rana Magar | ![]() |
![]() |
|||
129-OP | THE OUTCOME OF PLASMA CELL-RICH ACUTE REJECTION IN KIDNEY TRANSPLANTATION, IS IT REALLY POOR? | Tarek Mahmoud | ![]() |
![]() |
|||
131-OP | HYPERACUTE HUMORAL NON-HLA ALLOGRAFT REJECTION AND PROTEIN S DEFICIENCY DISEASE, CASE REPORT AND REVIEW. | Luis Garcia Covarrubias | ![]() |
![]() |
|||
132-OP | ALLOIMMUNE CELLULAR AND HUMORAL MONITORING IN A KIDNEY TRANSPLANT RECIPIENT THAT PRESENTS AN ACUTE LEUKEMIA TREATED WITH BLINATUMOMAB | Paula Anton Pampols | ![]() |
![]() |
|||
138-OP | ORGAN DONOR WITH RT-PCR POSITIVE FOR SARS-COV-2, IS IT ALWAYS NO? | José Moya Sánchez | ![]() |
![]() |
|||
139-OP | ORGAN DONATION IN KSA: COVID-19 PANDEMIC | Besher Al-Attar | ![]() |
![]() |
|||
140-OP | BILATERAL PNEUMONIA IN A KIDNEY TRANSPLANT RECIPIENT THE COVID-19 ERA- SOMETIMES IT´S A ZEBRA | Bojana Šimunov | ![]() |
![]() |
|||
141-OP | IMPACT OF THE CHANGE IN ORGAN DONATION LAW IN ENGLAND ON DONATION RATES IN THE MULTICULTURAL AND ETHNICALLY DIVERSE CITY OF LONDON | Lucy Dames | ![]() |
![]() |
|||
142-OP | OPT OUT LEGISLATION IN THE UK – PRELIMINARY DATA | Sue Madden | ![]() |
![]() |
|||
143-OP | DISPARITIES IN THE USE OF DONATION AFTER CARDIAC DEATH LIVER ALLOGRAFTS FROM DONORS OVER 60 YEARS OF AGE IN THE UNITED STATES VS. THE UNITED KINGDOM. | Emmanouil Giorgakis | ![]() |
![]() |
|||
145-OP | COMPUTERISED INTEGRATION OF ALTERNATIVE LIVING DONOR KIDNEY TRANSPLANTATION PROGRAMS: FIRST PROMISING RESULTS FOR DIFFICULT-TO-MATCH PATIENTS | Marry De Klerk | ![]() |
![]() |
|||
146-OP | ALTRUISTIC KIDNEY DONATIONS: OPTIMIZING UTILITY AND BENEFICENCE | Muhammad Yahya Jan | ![]() |
![]() |
|||
149-OP | BETA-CELL DEATH, RATHER THAN INSULIN RESISTANCE, DRIVES HYPERGLYCAEMIA IN ORGAN DONORS. | Iestyn Shapey | ![]() |
![]() |
|||
151-OP | DIFFERENTIALLY METHYLATED CELL FREE DNA MONITORING IN PANCREAS TRANSPLANT RECIPIENTS WITH FUNCTIONING GRAFT | Maria José Ramírez-Bajo | ![]() |
![]() |
|||
153-OP | UTILITY OF DONOR-DERIVED CELL-FREE DNA IN PANCREAS-KIDNEY TRANSPLANTATION | Pedro Ventura-Aguiar | ![]() |
![]() |
|||
154-OP | EFFICACY AND SAFETY OF PANCREAS TRANSPLANT ALONE (PTA) IN SUBJECTS WITH TYPE 1 DIABETES (T1D): 15 YEAR ACTUAL FOLLOW-UP | Walter Baronti | ![]() |
![]() |
|||
161-OP | THE EXPRESSION LEVELS OF CIRCULATING MIR-101 AND MIR-27 ASSOCIATE WITH HEART TRANSPLANT ACUTE REJECTION | Olga Gichkun | ![]() |
![]() |
|||
162-OP | REAL WORLD DATA OF EVEROLIMUS WITH OR WITHOUT CALCINEURIN-INHIBITORS ON LONGTERM OUTCOME AFTER HEART TRANSPLANTATION | Markus J. Barten | ![]() |
![]() |
|||
170-OP | MEDICATION ADHERENCE AND FEAR OF REJECTION AFTER CONVERSION FROM DUAL TO MONOTHERAPY: A RANDOMIZED CONTROLLED TRIAL | Regina Van Zanten | ![]() |
![]() |
|||
172-OP | I-DTI: A SECOND OPINION PLATFORM BETWEEN HEALTHCARE PROFESSIONALS RELATED TO ORGAN DONATION AND TRANSPLANTATION | Estephan Arredondo | ![]() |
![]() |
|||
176-OP | CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION | Angela Carvalho-Gomes | ![]() |
![]() |
|||
180-OP | RECIPIENT SEX AND ESTRADIOL LEVELS AFFECT TRANSPLANT OUTCOMES IN AN AGE-SPECIFIC FASHION | Jasper Iske | ![]() |
![]() |
|||
181-OP | CXCR3+ CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES COULD HELP IN COVID-19 RESOLUTION IN KIDNEY TRANSPLANT RECIPIENTS | Patricia Suàrez Fernández | ![]() |
![]() |
|||
182-OP | INCREASING DIAGNOSTIC ACCURACY IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE BY T CELL ANALYSIS IN PERIPHERAL BLOOD AND BIOPSY | Ulrik Stervbo | ![]() |
![]() |
|||
183-OP | DETECTION OF PRE-EXISTING SARS-COV-2-REACTIVE T CELLS IN UNEXPOSED RENAL TRANSPLANT PATIENTS | Arturo Blázquez Navarro | ![]() |
![]() |
|||
184-OP | COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS | Francisco Gonçalves | ![]() |
![]() |
|||
185-OP | OUTCOMES OF KIDNEY TRANSPLANTATION AT THE EPICENTRE OF THE COVID-19 PANDEMIC: THE EXPERIENCE OF THE OSPEDALE MAGGIORE POLICLINICO | Evaldo Favi | ![]() |
![]() |
|||
186-OP | IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION | Anna Sessa | ![]() |
![]() |
|||
187-OP | LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS RECOVERED FROM COVID-19 INFECTION | Ahad Eshraghian | ![]() |
![]() |
|||
188-OP | SARS-COV-2 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: ONE YEAR LATER. WHAT HAVE WE LEARNT? | Joana Tavares | ![]() |
![]() |
|||
189-OP | LIVER TRANSPLANT RECIPIENTS WITH SARS-COV-2 INFECTION: RESULTS FROM AN ITALIAN MULTICENTER COHORT | Chiara Mazzarelli | ![]() |
![]() |
|||
190-OP | COVID-19 MANAGEMENT IN PATIENTS AFTER HEART TRANSPLANTATION | Maria Simonenko | ![]() |
![]() |
|||
191-OP | COVID-19 IN DECEASED RENAL TRANSPLANT RECIPIENTS | Mariana Sousa | ![]() |
![]() |
|||
192-OP | EPIDEMIOLOGY AND CLINICAL RELEVANCE OF ACUTE KIDNEY INJURY IN COVID-19 KIDNEY TRANSPLANT RECIPIENTS | Gabriele Guglielmetti | ![]() |
![]() |
|||
193-OP | INFLUENZA VACCINATION IN SOLID ORGAN TRANSPLANT RECIPIENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY | Susanne Dam Nielsen | ![]() |
![]() |
|||
194-OP | KIDNEY TRANSPLANT PATIENTS ARE ABLE TO GENERATE AND MOUNT VARICELLA ZOSTER-REACTIVE T CELL AND HUMORAL IMMUNITY FOLLOWING VARICELLA ZOSTER VACCINATION | Toralf Roch | ![]() |
![]() |
|||
195-OP | CORRELATION BETWEEN COLD ISCHEMIA TIME AND THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION | Marco Maria Pascale | ![]() |
![]() |
|||
196-OP | DANGER SIGNALS IN ORGAN PRESERVATION SOLUTION AFTER COLD ISCHEMIA IN LIVER TRANSPLANTATION: ACTIVATION OF MACROPHAGES AND ENDOTHELIAL CELLS | Alberto Baroja-Mazo | ![]() |
![]() |
|||
197-OP | ROLE OF ACETYLCHOLINE IN LIVER GRAFTS FROM BRAIN DEAD DONORS WITH HEALTHY AND MARGINAL LIVERS WITH SIMPLE STEATOSIS OR NON-ALCOHOLIC STEATOHEPATITIS | Marc Micó Carnero | ![]() |
![]() |
|||
198-OP | PERSISTENT BILIARY HYPOXIA AND LACK OF REGENERATION ARE KEY MECHANISMS IN THE PATHOGENESIS OF NON-ANASTOMOTIC STRICTURES AFTER LIVER TRANSPLANTATION | Iris De Jong | ![]() |
![]() |
|||
199-OP | ANG-3777 TREATMENT ATTENUATES ISCHEMIA-REPERFUSION-INDUCED RENAL INJURY IN RAT AND DOG MODELS | Prakash Narayan | ![]() |
![]() |
|||
200-OP | INFLUENCE OF THE ANESTHETIC METHOD ON THE OUTCOME OF A RODENT MODEL OF INTESTINAL ISCHEMIA-REPERFUSION INJURY | Mathias Clarysse | ![]() |
![]() |
|||
201-OP | CLINICALLY APPLICABLE INTRALUMINAL PRESERVATION OF HUMAN SMALL BOWEL DOES NOT REDUCE HISTOLOGICAL DAMAGE COMPARED TO STANDARD VASCULAR FLUSH | Anne Marye De Jong | ![]() |
![]() |
|||
202-OP | CALCIUM CARBONATE NANOPARTICLES IN AN EX VIVO RAT INTESTINAL PERFUSION MODEL: PREVENTION OF ISCHEMIC INJURY IN COLON AND SMALL INTESTINE | Michele Finotti | ![]() |
![]() |
|||
203-OP | L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODE | Michele Finotti | ![]() |
![]() |
|||
204-OP | ATTENUATION OF INTESTINAL ISCHEMIA-REPERFUSION INJURY IN A RODENT MODEL BY INTRAVENOUS ADMINISTRATION OF POLYETHYLENE GLYCOL | Mathias Clarysse | ![]() |
![]() |
|||
205-OP | IN VIVO PHOSPHORYLATION OF C-MET BY ANG-3777, A HEPATOCYTE GROWTH FACTOR MIMETIC | Latha Paka | ![]() |
![]() |
|||
206-OP | OXYGENATED VERSUS NON-OXYGENATED FLUSH OUT AND STORAGE OF DCD PORCINE LIVERS | Isabel Brüggenwirth | ![]() |
![]() |
|||
207-OP | THE IRRADIATION-INDUCED RENAL ISCHEMIC PRECONDITIONING IS BLUNTED BY THE ORAL ADMINISTRATION OF THE ANTI-ANGIOGENIC AGENT, SUNITINIB | Badr Khbouz | ![]() |
![]() |
|||
208-OP | ILOPROST INFUSION ACCELERATES THE RECOVERY OF RENAL FUNCTION IN PATIENTS EXPERIENCING IRI-RELATED DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANT | Antonella Troiano | ![]() |
![]() |
|||
209-OP | IDENTIFICATION OF PREDICTIVE MARKERS FOR THE GENERATION OF WELL-DIFFERENTIATED IPSC-DERIVED KIDNEY ORGANOIDS | Zhaoyu Du | ![]() |
![]() |
|||
211-OP | PORTAL VENOUS REPOPULATION OF DECELLULARISED RAT LIVER SCAFFOLDS WITH SYNGENEIC BONE MARROW STEM CELLS | Mekhola Hoff | ![]() |
![]() |
|||
215-OP | IMPACT OF DELAYED GRAFT FUNCTION ON BASELINE DONOR DERIVED CELL-FREE DNA (DD-CFDNA) IN KIDNEY TRANSPLANT RECIPIENTS | Bhavna Chopra | ![]() |
![]() |
|||
220-OP | DIFFERENTIALLY EXPRESSED TISSUE MICRORNAS DISTINGUISH SPECIFIC DISEASE PHENOTYPES FOLLOWING KIDNEY TRANSPLANTATION | Špela Borštnar | ![]() |
![]() |
|||
228-OP | MAINTENANCE OF A DECEASED-DONOR KIDNEY TRANSPLANTATION PROGRAM DURING PANDEMIC SARS-COV-2 | Richard Dumbill | ![]() |
![]() |
|||
230-OP | IS IT SAFE TO RECEIVE KIDNEYS FROM DECEASED KIDNEY DONORS WHO TESTED POSITIVE FOR COVID-19 INFECTION? | Hatem Ali | ![]() |
![]() |
|||
231-OP | A NATIONAL RESPONSE TO COVID PRIORITISING LIVER TRANSPLANT RECIPIENTS WITH THE HIGHEST NEED PROVIDED EXCELLENT OUTCOMES IN THE UK | Steven Masson | ![]() |
![]() |
|||
232-OP | COVID-19 IN LIVER TRANSPLANT CANDIDATES: WAIT-LIST OUTCOMES AND POST-TRANSPLANT COURSE | Giovanni Perricone | ![]() |
![]() |
|||
233-OP | PANCREAS TRANSPLANTATION IN THE TIME OF COVID. A SINGLE CENTRES EXPERIENCE | Ann Etohan Ogbemudia | ![]() |
![]() |
|||
234-OP | A CASE SERIES OF PAEDIATRIC KIDNEY TRANSPLANTS DURING THE ONGOING COVID-19 PANDEMIC | Sergio Assia-Zamora | ![]() |
![]() |
|||
235-OP | ANASTOMOSIS TIME IS AN INDEPENDENT RISK FACTOR FOR PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY | Christelle M. Vandervelde | ![]() |
![]() |
|||
236-OP | FEASIBILITY OF SURVEILLANCE AFTER LUNG TRANSPLANTATION USING MULTIVOLUME MRI INSTEAD OF IONIZING RADIATION TECHNIQUES IN CYSTIC FIBROSIS PATIENTS | Alessandro Palleschi | ![]() |
![]() |
|||
237-OP | CHRONIC KIDNEY DISEASE: A FREQUENT COMPLICATION IN PATIENTS WITH LUNG TRANSPLANT | Marisa Serrano Salazar | ![]() |
![]() |
|||
238-OP | COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG | Víctor Donoso Trenado | ![]() |
![]() |
|||
239-OP | CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN | Raquel López-Vilella | ![]() |
![]() |
|||
240-OP | IS HEART TRANSPLANTATION A VALUABLE OPTION IN PATIENTS WITH SYSTEMIC RARE DISEASES? | Concetta Di Nora | ![]() |
![]() |
|||
241-OP | SINGLE CENTER ASSESSMENT OF CARDIAC TRANSPLANTATION RESULTS COMPARING URGENT VERSUS ELECTIVE REGIMEN | Mariafrancesca Fiorentino | ![]() |
![]() |
|||
242-OP | WAITLIST OUTCOMES AFTER THE IMPLEMENTATION OF A NEW ALLOCATION SYSTEM FOR URGENT HEART TRANSPLANTATION IN ITALY | Alessandra Oliveti | ![]() |
![]() |
|||
243-OP | LIFE OF AN HEART FAILURE AND HEART TRANSPLANT CENTER IN THE COVID ERA : NEVER GIVE IN TO FEAR, USE TELEMEDICINE. | Marco Masetti | ![]() |
![]() |
|||
244-OP | MYOCARDIAL SCAR BURDEN CORRELATES WITH CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION AND NT-PROBNP SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | ![]() |
![]() |
|||
245-OP | DECREASED CIRCULATING CD34+ CELL COUNT IS ASSOCIATED WITH CORONARY ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | ![]() |
![]() |
|||
246-OP | MONITORING LYMPHOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD IN HEART TRANSPLANT RECIPIENTS. A NEW TOOL TO DETECT CAV? | Clara Simón Ramón | ![]() |
![]() |
|||
247-OP | RISK FACTORS AND OUTCOMES OF ACUTE KIDNEY INJURY AFTER HEART TRANSPLANT | Nicolina Conti | ![]() |
![]() |
|||
248-OP | THE RISK OF SKIN CANCER DOES NOT CORRELATE WITH VITAMIN D SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | ![]() |
![]() |
|||
249-OP | MAGNETIC RESONANCE IMAGING TO ASSESS RENAL FLOW DISTRIBUTION DURING EX VIVO NORMOTHERMIC MACHINE PERFUSION | Veerle A. Lantinga | ![]() |
![]() |
|||
251-OP | DONATION AFTER CIRCULATORY DEATH (DCD) STRATEGY IN ITALY: THE BARRIER OF A PROLONGED NO-TOUCH PERIOD CAN BE OVERCOME | Lucia Masiero | ![]() |
![]() |
|||
252-OP | NORMOTHERMIC LIQUID VENTILATION ATTENUATES INFLAMMATION FROM ISCHEMIA-REPERFUSION INJURY IN AN EX VIVO RAT MODEL | Helena M. Linge | ![]() |
![]() |
|||
253-OP | NORMOTHERMIC MACHINE PERFUSION FACILITATES DELIVERY OF RNA INTERFERENCE THERAPEUTICS IN DONOR KIDNEYS | Emily Thompson | ![]() |
![]() |
|||
254-OP | TREATING CIRCULATORY DEATH DONOR KIDNEYS WITH ANTI-FIBROTIC DRUGS USING EX VIVO PRECISION CUT KIDNEY SLICES | Leonie Van Leeuwen | ![]() |
![]() |
|||
255-OP | COMPLEMENT IS ACTIVATED DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE AND DISCARDED HUMAN KIDNEYS | Leonie Venema | ![]() |
![]() |
|||
256-OP | NORMOTHERMIC REGIONAL PERFUSION VERSUS RAPID RECOVERY IN CONTROLLED DONATION AFTER CIRCULATORY DEATH KIDNEY TRANSPLANTATION | Maria Padilla | ![]() |
![]() |
|||
257-OP | IMMUNE CELL PROFILING AND ASSESSMENT OF INFLAMMATORY CYTOKINE LEVELS IN THE PERFUSATE DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN LIVER ALLOGRAFTS | Margot Fodor | ![]() |
![]() |
|||
258-OP | EXPLORING THE RELEASE OF EXTRACELLULAR VESICLES IN PERFUSATE AND BILE AS AN ADDITIONAL TOOL TO UNRAVEL MECHANISMS OF FUNCTION OF LIVER NMP. | Nicholas Gilbo | ![]() |
![]() |
|||
259-OP | METABOLIC AND IMMUNOLOGICAL ALTERATIONS IN NORMOTHERMIC MACHINE PERFUSION OF THE LIVER AS COMPARED TO STATIC COLD STORAGE | Maria Letizia Lo Faro | ![]() |
![]() |
|||
261-OP | MICROVASCULAR OBSTRUCTIONS IN PORTAL BILE DUCT CAPILLARIES AND HEPATIC SINUSOIDS DURING NORMOTHERMIC MACHINE PERFUSION OF MARGINAL HUMAN LIVERS | Samuel Tingle | ![]() |
![]() |
|||
262-OP | RE-WRITING THE DEFINITION OF HIGH-RISK AND FUTILE DCD LIVER TRANSPLANTATION WITH NRP | Ahmed E Sherif | ![]() |
![]() |
|||
263-OP | BENCH SURGERY AND KIDNEY AUTO-TRANSPLANTATION IN RESCUE OF GERM-CELL RESIDUAL MASS. 3D MODELS UTILITY IN SURGICAL PLANNING | Victoria Gomez | ![]() |
![]() |
|||
265-OP | AN ALTERNATIVE WAY OF LAPAROSCOPIC PERITONEAL FENESTRATION BY USING A SECOND LAPAROSCOPE AND TRANSILLUMINATION TO MANAGE POST-TRANSPLANT LYMPHOCELES | Vasileios Tatsis | ![]() |
![]() |
|||
271-OP | INEQUITABLE ACCESS TO TRANSPLANTS: PERSONS WITH IMPAIRED DECISION-MAKING CAPACITY | Rebecca Thom | ![]() |
![]() |
|||
272-OP | FRIEND OR FOE: LAW, REGULATION AND THE PSYCHOSOCIAL ASSESSMENT OF LIVING KIDNEY DONORS | Bonnie Venter | ![]() |
![]() |
|||
273-OP | FAMILY´S LEGAL ROLE IN DECEASED ORGAN PROCUREMENT. AN EUROPEAN AND COMPARATIVE LAW STUDY | Marina Morla | ![]() |
![]() |
|||
274-OP | WITHDRAWING LIFE SUSTAINING TREATMENT AND ORGAN DONATION OF BRAIN DEATH PATIENTS | Seungrye Jeong | ![]() |
![]() |
|||
276-OP | H2S ENRICHED FLUSH-OUT IN DBD AND NON-DBD PORCINE KIDNEYS | Hanno Maassen | ![]() |
![]() |
|||
277-OP | PATTERNS AND INHIBITION OF CELL DEATH DURING STATIC COLD STORAGE OF HUMAN KIDNEYS | Jenna DiRito | ![]() |
![]() |
|||
278-OP | COMBINED DRUGS APPROACH TO PREVENT ISCHEMIA-REPERFUSION INJURY DURING TRANSPLANTATION OF LIVERS (CAPITL): RESULTS OF A RANDOMIZED CONTROLLED TRIAL | Nicolas Meurisse | ![]() |
![]() |
|||
280-OP | MODIFIED IMMUNE CELL (MIC) INFUSION IN KIDNEY TRANSPLANTATION | Christian Morath | ![]() |
![]() |
|||
281-OP | CHARACTERISATION OF DISTINCT GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS | Matthew Brook | ![]() |
![]() |
|||
282-OP | LONG TERM FOLLOW-UP OF LIVER TRANSPLANT RECIPIENTS AFTER ALLOGENEIC MESENCHYMAL STROMAL CELL INFUSION | Morgan Vandermeulen | ![]() |
![]() |
|||
283-OP | INCIDENCE AND PREDICTORS OF FAILED KIDNEY ALLOGRAFT INTOLERANCE SYNDROME | Carolina Ormonde | ![]() |
![]() |
|||
284-OP | LONG-TERM APHERESIS IN THE MANAGEMENT OF PATIENTS WITH RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION: A CASE SERIES | Audrey Uffing | ![]() |
![]() |
|||
285-OP | TRANSPLANTECTOMY VERSUS NON-TRANSPLANTECTOMY AFTER FAILED KIDNEY TRANSPLANT. A SYSTEMATIC REVIEW AND META-ANALYSIS. | Paschalis Gavriilidis | ![]() |
![]() |
|||
286-OP | ASSOCIATION BETWEEN DECEASED DONOR ACUTE KIDNEY INJURY ASSESSED BY BASELINE SERUM CREATININE BACK-ESTIMATION AND GRAFT SURVIVAL | Rémi Lenain | ![]() |
![]() |
|||
287-OP | CLINICAL AND IMMUNOLOGICAL FOLLOW-UP OF VERY LONG-TERM KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CALCINEURIN INHIBITORS | Amaury Dujardin | ![]() |
![]() |
|||
288-OP | DEEP-LEARNING BASED PREDICTION OF CLINICAL ENDPOINTS IN RENAL PRE-IMPLANTATION BIOPSIES USING SLIDE-LEVEL LABELS | Ka Ho Tam | ![]() |
![]() |
|||
289-OP | MOLECULAR AND CELLULAR MECHANISMS OF LIPOCALIN-2 MEDIATED RENOPROTECTION IN KIDNEY TRANSPLANTATION | Anna Pfefferkorn | ![]() |
![]() |
|||
290-OP | REVISITING THE CHANGES IN THE BANFF CLASSIFICATION FOR ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION | Jasper Callemeyn | ![]() |
![]() |
|||
291-OP | INTERSTITIAL FIBROSIS IN PREIMPLANTATION KIDNEY BIOPSIES OF EXTENDED CRITERIA DONORS PREDICTS LONG-TERM GRAFT SURVIVAL. | Elisabetta Bussalino | ![]() |
![]() |
|||
292-OP | THREE-MONTH GRAFT FUNCTION OF KIDNEYS RETRIEVED 4.5 HOURS AFTER CIRCULATORY DEATH | Deepti Antony | ![]() |
![]() |
|||
293-OP | ENDOTHELIAL TO MYOFIBROBLAST TRANSITION (ENMT) AND CAPILLARY VEGF LOSS ENHANCES THE DEVELOPMENT OF INTERSTITIAL FIBROSIS AND GLOMERULOSCLEROSIS | Binnaz Handan Ozdemir | ![]() |
![]() |
|||
294-OP | AGGRAVATION OF FIBRIN DEPOSITION AND MICROTHROMBUS FORMATION WITHIN THE GRAFT DURING KIDNEY TRANSPLANTATION | Tamar Van Den Berg | ![]() |
![]() |
|||
295-OP | HYPERLEPTINAEMIA AND LOW VALUES OF INTERLEUKIN 10 AS RISK FACTORS FOR GRAFT REJECTION IN PROTOCOL BIOPSY AFTER KIDNEY TRANSPLANTATION | Ivana Dedinská | ![]() |
![]() |
|||
296-OP | POST-TRANSPLANTATION EARLY BLOOD TRANSFUSION AND KIDNEY ALLOGRAFT OUTCOMES: A SINGLE-CENTER OBSERVATIONAL STUDY | Mehdi Maanaoui | ![]() |
![]() |
|||
299-OP | CORE SIGNATURE OF REJECTION-SPECIFIC CYTOKINES AND CHEMOKINES IN HEART BIOPSIES AFTER TRANSPLANTATION | Lena Radomsky | ![]() |
![]() |
|||
301-OP | CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE SCREENING OF CARDIAC ALLOGRAFT VASCULOPATHY, TWO YEARS OF EXPERIENCE | Stefan Roest | ![]() |
![]() |
|||
309-OP | MALIGNANCIES BEFORE AND AFTER HEART TRANSPLANTATION – A SINGLE-CENTRE LONG-TERM OUTCOME STUDY | Caroline Stenman | ![]() |
![]() |
|||
310-OP | CANCER TRANSMISSIONS AND NON-TRANSMISSIONS FROM SOLID ORGAN TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY | James Hedley | ![]() |
![]() |
|||
311-OP | SURVIVAL WITH TABELECLEUCEL IN PATIENTS WITH EPSTEIN-BARR VIRUS-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER SOLID ORGAN TRANSPLANT | S Prockop | ![]() |
![]() |
|||
312-OP | DONOR-TRANSMITTED CANCERS: THE SPANISH EXPERIENCE | Beatriz Dominguez-Gil | ![]() |
![]() |
|||
313-OP | SERIOUS ADVERSE EVENTS (SAE) AND SERIOUS ADVERSE REACTIONS (SAR) REPORTING IN GERMANY FROM 2016-2020: ANALYSIS OF DONOR-TRANSMITTED MALIGNANCY. | Klaus Böhler | ![]() |
![]() |
|||
314-OP | HETEROGENEOUS INFLUENCE OF DIFFERENT FORMS OF POST-TRANSPLANT DE NOVO CANCER ON SURVIVAL OF KIDNEY GRAFTS – A COLLABORATIVE TRANSPLANT STUDY REPORT | Christian Unterrainer | ![]() |
![]() |
|||
315-OP | POST-TRANSPLANT MALIGNANCIES AFTER PANCREAS TRANSPLANTATION: INCIDENCE AND IMPLICATIONS ON LONG-TERM OUTCOME FROM A SINGLE-CENTER PERSPECTIVE | Felix Julius Krendl | ![]() |
![]() |
|||
316-OP | T AND B CELL ABUNDANCE ARE STRONGLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES | Simon Schran | ![]() |
![]() |
|||
317-OP | IMPACT OF CANCER ON THE RISK OF DEATH AMONG ITALIAN KIDNEY TRANSPLANT RECIPIENTS WITH A FUNCTIONING GRAFT: ITALIAN TRANSPLANT & CANCER COHORT STUDY | Pierluca Piselli | ![]() |
![]() |
|||
318-OP | MANAGEMENT OF THE KIDNEY TRANSPLANT PATIENT WITH CANCER": REPORT FROM A CONSENSUS CONFERENCE. | Gionata Spagnoletti | ![]() |
![]() |
|||
319-OP | RETROSPECTIVE STUDY OF NEOPLASM TRANSMISSION FROM ORGAN DONOR TO RECIPIENT | Helena Martí Grífol | ![]() |
![]() |
|||
320-OP | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY | Stathis Tsiakas | ![]() |
![]() |
|||
321-OP | DISTINCT IMPACT OF POSTTRANSPLANT MALIGNANCIES AND MORTALITY IN DIFFERENT IMMUNOSUPPRESSIVE THERAPY PROTOCOLS BASED- PERIODS IN A LONG-TERM FOLLOW-UP | Ignacio Revuelta | ![]() |
![]() |
|||
322-OP | PREVALENCE AND CLINICAL SIGNIFICANCE OF PANCREATIC CYSTIC LESIONS IN IMMUNOSUPPRESSED PATIENTS WITH SOLID ORGAN TRANSPLANTATION | Young-Dong Yu | ![]() |
![]() |
|||
325-OP | PHASE 3 OPEN-LABEL STUDY OF MARIBAVIR FOR REFRACTORY/RESISTANT CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS: SUBGROUP ANALYSES BY ORGAN TYPE | Nassim Kamar | ![]() |
![]() |
|||
326-OP | SURVEILLANCE AND TREATMENT OF HUMAN HERPESVIRUS 8 IN TRANSPLANT RECIPIENTS: A STRICT PROTOCOL TO BRING MORTALITY TOWARD ZERO | alessandra mularoni | ![]() |
![]() |
|||
327-OP | MTOR INHIBITORS PREVENT CMV INFECTION THROUGH THE RESTORATION OF FUNCTIONAL ?? AND G? T CELLS IN KIDNEY TRANSPLANTATION | hannah kaminski | ![]() |
![]() |
|||
328-OP | PRECISION MEDICINE IN TRANSPLANTATION: MAGNITUDE, DURATION, AND IMPACT OF CMV VIREMIA ON GRAFT AND MORTALITY OUTCOMES | Paul A Keown | ![]() |
![]() |
|||
330-OP | BARIATRIC SURGERY COMPROMISES MACROPHAGE DRIVEN ALLOIMMUNITY IN OBESE TRANSPLANT RECIPIENTS | Jasper Iske | ![]() |
![]() |
|||
331-OP | MAXIMIZE THE USE OF ARTIFICIAL INTELLIGENCE IN ORGAN DONATION AND TRANSPLANTATION MANAGEMENT TO IMPROVE EFFICACY AND SAFETY | Wenshi Jiang | ![]() |
![]() |
|||
332-OP | OUTPATIENT URETERIC STENT REMOVAL FROM KIDNEY TRANSPLANT RECIPIENTS USING ISIRIS IS FEASIBLE, SAFE AND COST-EFFECTIVE | Fanourios Georgiades | ![]() |
![]() |
|||
333-OP | MULTILINEAR EGFR PROGRESSION PATTERN IS ASSOCIATED WITH GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS | Ruth Rahamimov | ![]() |
![]() |
|||
334-OP | PERSPECTIVES OF AUTOLOGOUS BLOOD TRANSFUSION AS A TOOL FOR PREVENTING IMMUNIZATION DURING NATIVE KIDNEY NEPHRECTOMY IN WAITING LIST CANDIDATES | Alicja Debska-Slizien | ![]() |
![]() |
|||
335-OP | QUALITY OF LIFE AFTER LIVER TRANSPLANTATION, A CROSS-SECTIONAL SINGLE CENTRE STUDY. | Mathias Vidgren | ![]() |
![]() |
|||
336-OP | QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY | Midas Mulder | ![]() |
![]() |
|||
337-OP | COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS | Midas Mulder | ![]() |
![]() |
|||
338-OP | CLIF-C ACLF SCORE DOES NOT PREDICT SURVIVAL AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE | Joris Blondeel | ![]() |
![]() |
|||
339-OP | LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE: A SINGLE CENTRE EXPERIENCE | Joris Blondeel | ![]() |
![]() |
|||
340-OP | VARIOUS SELECTION CRITERIA FOR PRETRANSPLANT MYOSTEATOSIS AND THEIR VALUE IN THE ASSESSMENT OF SHORT- AND LONG-TERM OUTCOMES FOLLOWING OLT | Zoltan Czigany | ![]() |
![]() |
|||
341-OP | ULTRA-LONG-TERM OUTCOME AND ITS DETERMINANTS AFTER LIVER TRANSPLANTATION IN ADULTS | Laura Boer | ![]() |
![]() |
|||
342-OP | THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY? | Michel Rayar | ![]() |
![]() |
|||
343-OP | A PHOTOGRAPH OF PATIENTS APPROACHING LIVER TRANSPLANTATION: ASSESSMENT OF THE PSYCHOLOGICAL OUTCOME PREDICTORS | Marco Valente | ![]() |
![]() |
|||
344-OP | AN ECONOMIC EVALUATION OF THE COST OF COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION IN THE UK NATIONAL HEALTH SYSTEM | Dimitri A. Raptis | ![]() |
![]() |
|||
346-OP | VIEWS AND EXPERIENCES OF PATIENTS AWAITING A TRANSPLANT AND OF TRANSPLANTED PATIENTS: A NATIONAL SURVEY TO UNDERSTAND THEIR NEEDS | Lia Bellis | ![]() |
![]() |
|||
348-OP | PSYCHOLOGICAL EVALUATION OF DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING COVID-19 | Sanem Cimen | ![]() |
![]() |
|||
352-OP | BILIARY RECONSTRUCTION USING HIGH BILIARY RADICAL IS SAFE OPTION FOR MULTIPLE GRAFT BILE DUCT IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION | JOODONG KIM | ![]() |
![]() |
|||
353-OP | RE-THINKING OF T-TUBE USE AT WHOLE LIVER TRANSPLANTATION: AN ANALYSIS ON THE RISK OF DELAYED GRAFT FUNCTION | Riccardo Pravisani | ![]() |
![]() |
|||
354-OP | POST-LIVER TRANSPLANT INFERIOR VENA CAVA STENOSIS IN A LARGE VOLUME UK CENTRE. | Fanourios Georgiades | ![]() |
![]() |
|||
356-OP | PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES | Domenico Pinelli | ![]() |
![]() |
|||
357-OP | EFFECT OF PRE-TRANSPLANT SARCOPENIA ON THE ESTIMATION OF STANDARD LIVER VOLUME IN LIVING-DONOR LIVER TRANSPLANT CANDIDATES | Riccardo Pravisani | ![]() |
![]() |
|||
358-OP | A PROSPECTIVE ANALYSIS OF CLINICAL FRAILTY ASSESSMENT AND TELOMERE LENGTH IN A NATIONAL COHORT OF LIVER TRANSPLANT CANDIDATES | Sinead Cremen | ![]() |
![]() |
|||
359-OP | FAST-TRACK LIVER TRANSPLANTATION: 100 MONTHS OF A FULL-FLEDGED ERAS PROTOCOL | Gonzalo Rodríguez-Laiz | ![]() |
![]() |
|||
360-OP | ARE WE READY FOR BARIATRIC SURGERY IN A LIVER TRANSPLANT PROGRAM? A META-ANALYSIS | Victor López-López | ![]() |
![]() |
|||
369-OP | OUTCOMES OF RABBIT ANTI-THYMOCYTE GLOBULIN VERSUS IL-2 RA INDUCTION THERAPIES IN 2DR MISMATCH RENAL TRANSPLANT RECIPIENTS | Hatem Ali | ![]() |
![]() |
|||
373-OP | GRAFT UTILIZATION AFTER NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH - 5-YEAR EXPERIENCE FROM FRANCE | Xavier Muller | ![]() |
![]() |
|||
374-OP | HYPOTHERMIC OXYGENATED MACHINE PERFUSION (HOPE) IN LIVER TRANSPLANTATION FOR EXPANDED CRITERIA DONOR GRAFT: SINGLE CENTER EXPERIENCE | Luca Perin | ![]() |
![]() |
|||
380-OP | OPERATIONAL TOLERANCE-RELATED GENES ALLOW NON-INVASIVE DETECTION OF SUBCLINICAL REJECTION AT ONE YEAR AFTER RENAL TRANSPLANTATION | Richard Danger | ![]() |
![]() |
|||
382-OP | AGE-RELATED PROTEOMIC DIFFERENCES IN DECEASED DONOR KIDNEYS ASSOCIATE WITH 12-MONTH POSTTRANSPLANTATION OUTCOME | Philip Charles | ![]() |
![]() |
|||
384-OP | SUBOPTIMAL RECIPIENT OUTCOMES CORRELATE TO INCREASED INFLAMMATORY MARKERS IN DECEASED AFTER BRAIN DEATH DONORS | Rebecca Vaughan | ![]() |
![]() |
|||
387-OP | THE EFFECT OF DONOR DIABETES-ASSOCIATED GENOTYPES ON OUTCOMES AFTER PANCREAS TRANSPLANTATION. | Charles Sneddon | ![]() |
![]() |
|||
388-OP | PANCREAS TRANSPLANTATION FROM DONORS DECLARED DEATH BY CIRCULATORY CRITERIA: INITIAL EXPERIENCE IN SPAIN. | Joana Ferrer | ![]() |
![]() |
|||
389-OP | METABOLIC OUTCOMES OF PANCREAS TRANSPLANT ALONE FROM DONATION AFTER CIRCULATORY DEATH DONORS - THE UK REGISTRY ANALYSIS | Jeevan Gopal | ![]() |
![]() |
|||
390-OP | HUMAN AMNIOTIC EPITHELIAL CELLS PROTECT PANCREATIC ISLETS AGAINST PRO-INFLAMMATORY CYTOKINES | Fanny Lebreton | ![]() |
![]() |
|||
391-OP | OUTCOMES OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS FROM DONATION AFTER CIRCULATORY DEATH DONORS IN THE UK: A NATIONAL REGISTRY ANALYSIS | Nikolaos Karydis | ![]() |
![]() |
|||
392-OP | DEVELOPMENT OF EX VIVO NORMOTHERMIC PERFUSION AS AN INNOVATIVE METHOD TO ASSESS PANCREASES AFTER PRESERVATION | Ann Etohan Ogbemudia | ![]() |
![]() |
|||
393-OP | THE EUROPEAN P-PASS AND US PDRI SCORES ARE ASSOCIATED WITH INCREASED RISK OF PANCREAS GRAFT REJECTION | Ky-Leigh Ang | ![]() |
![]() |
|||
394-OP | IMPROVED PANCREATIC GRAFTS SURVIVAL WITH OPERATING PROTOCOL AMENDMENTS. | Pawel Skrzypek | ![]() |
![]() |
|||
395-OP | POST-TRANSPLANT INFLAMMATION IS LOCALISED TO THE PANCREAS GRAFT AND ASSOCIATED WITH EARLY GRAFT THROMBOSIS | Kristina Rydenfelt | ![]() |
![]() |
|||
396-OP | COMPARISON OF DRB1 AND DQB1 ALLELE FREQUENCIES AND PRE-TRANSPLANT ANTI-HLA ANTIBODIES IN PATIENTS WAITING FOR PANCREAS VS. KIDNEY TRANSPLANT | Eric Kauffman | ![]() |
![]() |
|||
397-OP | TEN YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATIONS - SINGLE CENTRE NATIONWIDE EXPERIENCE | Kaisa Ahopelto | ![]() |
![]() |
|||
398-OP | PANCREAS GRAFT SALVAGE AFTER DUODENAL LEAK - FOLEY OR FOLLY? OUTCOMES FROM OVER 1000 PANCREAS TRANSPLANTS | Fungai Dengu | ![]() |
![]() |
|||
399-OP | FIRST POSTOPERATIVE DAY PLASMA AMYLASE CAN BE USED TO DETECT PATIENTS AT RISK OF COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Akseli Bonsdorff | ![]() |
![]() |
|||
400-OP | ISLETS LOADED IN HYDROGEL DERIVED FROM HUMAN AMNIOTIC MEMBRANE REVERSE DIABETES IN IMMUNODEFICIENT MICE | Kevin Bellofatto | ![]() |
![]() |
|||
401-OP | BLOCKADE OF THE IL-21 PATHWAY: A NEW PERSPECTIVE FOR THE TREATMENT OF T AND B CELL MEDIATED ALLOGENEIC RESPONSES AFTER TRANSPLANTATION | Carla Baan | ![]() |
![]() |
|||
402-OP | PROLIFERATION OF CO-STIMULATION BLOCKADE RESISTANT-T CELLS REQUIRED EARLY IFN? PATHWAY ACTIVATION | Florence Herr | ![]() |
![]() |
|||
403-OP | DETERMINING THE T CELLRECEPTOR REPERTOIRE IN DIRECT PEPTIDE-MHC ALLORECOGNITION BY CD8+ T CELLS | Alexandra Sharland | ![]() |
![]() |
|||
404-OP | INCREASED FREQUENCY OF T CELL-MEDIATED REJECTION ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN HLA-DSA NEGATIVE TRANSPLANT RECIPIENTS | David Rodriguez Fuentes. | ![]() |
![]() |
|||
405-OP | DO NOT BLAME THE INNOCENT: G?T CELLS ARE NOT INVOLVED IN DONOR SPECIFIC ANTIBODY GENERATION AFTER SOLID ORGAN TRANSPLANTATION | Xavier Charmetant | ![]() |
![]() |
|||
406-OP | IMMUNOLOGICAL BEHAVIOR OF EARLY GRAFT INFILTRATING CELLS UNTIL 3 DAYS AFTER MURINE SKIN TRANSPLANTATION | Ryo Kanazawa | ![]() |
![]() |
|||
407-OP | GENOME-WIDE MISMATCH AND DELETION ANALYSIS IN KIDNEY TRANSPLANTATION | Salla Markkinen | ![]() |
![]() |
|||
408-OP | DONOR-RECIPIENT GENETIC MISMATCH IS ASSOCIATED WITH LIVER ALLOGRAFT REJECTION | Lianne Nieuwenhuis | ![]() |
![]() |
|||
409-OP | SOLVENT ACCESSIBLE AMINO ACID MISMATCHES CALCULATED BY HLA-EMMA AS INDEPENDENT RISK FACTOR FOR DEATH-CENSORED GRAFT FAILURE IN RENAL TRANSPLANTATION | Suzanne Bezstarosti | ![]() |
![]() |
|||
410-OP | LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION | Florian Kälble | ![]() |
![]() |
|||
411-OP | ANTI-THYMOCYTE GLOBULIN MEDIATED B-CELL ACTIVATION | Moritz Muckenhuber | ![]() |
![]() |
|||
412-OP | MESENCHYMAL STROMAL CELL DERIVED MEMBRANE PARTICLES ARE INTERNALIZED BY MACROPHAGES AND ENDOTHELIAL CELLS AND EXHIBIT IMMUNOMODULATORY EFFECTS | Martin Hoogduijn | ![]() |
![]() |
|||
413-OP | DELINEATING THE IMMUNOGENICITY OF GRAFT COMPONENTS IN COMPOSITE TISSUE ALLOTRANSPLANTATION | Barbara Kern | ![]() |
![]() |
|||
414-OP | LOCAL IMMUNOSUPPRESSION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: PAVING THE WAY FOR A SAFER ALTERNATIVE | Isabel Arenas Hoyos | ![]() |
![]() |
|||
415-OP | MANAGEMENT OF CONGENITAL PORTOSYSTEMIC SHUNTS | Lilia Martinez de la maza | ![]() |
![]() |
|||
416-OP | HEPATOPORTOENTEROSTOMY VERSUS PRIMARY LIVER TRANSPLANTATION FOR BILIARY ATRESIA | Dor Yoeli | ![]() |
![]() |
|||
417-OP | THE ROLE OF VASCULAR ADHESION PROTEIN-1 IN THE PATHOGENESIS OF CHRONIC ALLOGRAFT HEPATITIS AFTER PAEDIATRIC LIVER TRANSPLANTATION | Steffen Hartleif | ![]() |
![]() |
|||
418-OP | VEIN OUTFLOW OBSTRUCTION AFTER LEFT LATERAL SEGMENTS TRANSPLANT: EXPERIENCE AT A LARGE PEDIATRIC TRANSPLANTATION CENTER. | Domenico Pinelli | ![]() |
![]() |
|||
419-OP | LIVER TRANSPLANTATION FOR LANGERHANS CELL HISTIOCYTOSIS : A PROTOCOL BASED APPROACH | Jagadeesh Menon | ![]() |
![]() |
|||
421-OP | KIDNEY TRANSPLANTATION IN THE TRANSGENDER PATIENT- A CHALLENGE FOR CARE | Irena Milaniak | ![]() |
![]() |
|||
422-OP | FIRST PERSON CONSENT: CHALLENGES TO APPROACHING FOR DONATION. | Bethany Hall | ![]() |
![]() |
|||
424-OP | COLLABORATIVE WORKING- KEY TO MAINTAINING NORMAL ORGAN DONATION AND TRANSPLANT SERVICE DURING COVID PANDEMIC IN NORTHERN IRELAND | Mary Hayes | ![]() |
![]() |
|||
431-OP | SYSTEMATIC SCREENING FOR SARS-COV-2 S1/S2 ANTIBODIES HELPS TO BETTER ASSESS THE REAL INCIDENCE OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS | Louis Firket | ![]() |
![]() |
|||
432-OP | COMPARISON OF THE IMMUNE RESPONSES OF RENAL TRANSPLANT RECIPIENTS AFTER COVID-19 VERSUS SARS-COV2 VACCINATION | Xavier Charmetant | ![]() |
![]() |
|||
434-OP | INCREASE ORGANS PROCURED AND TRANSPLANTED VIA A COMPREHENSIVE, INTEROPERABLE, AND SECURE DIGITAL DONOR AND TRANSPLANT MANAGEMENT PLATFORM | John Piano | ![]() |
![]() |
|||
435-OP | IMPACT ON DONOR DETECTION AFTER THE IMPLEMENTATION OF QUALITY INDICATORS AND TPM TRAINING PROGRAM IN THE KINGDOM OF SAUDI ARABIA | Estephan Arredondo | ![]() |
![]() |
|||
436-OP | THE DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION FROM 1998 TO 2019: RESULTS | Carlo De Cillia | ![]() |
![]() |
|||
437-OP | ORGAN DONATION AND TRANSPLANT IN THE ENGLISH-SPEAKING CARIBBEAN REGION: 10 YEARS OF INTERNATIONAL COOPERATION | Maria Gomez | ![]() |
![]() |
|||
438-OP | QUALITY MANAGEMENT SYSTEM APPLIED TO ORGAN DONATION: UNITED ARAB EMIRATES EXPERIENCE | Maria Gomez | ![]() |
![]() |
|||
439-OP | SOLUBLE UROKINASE RECEPTOR AND MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS | Christian Morath | ![]() |
![]() |
|||
440-OP | COMPARATIVE TRANSCRIPTOME ANALYSIS REVEALS A POTENTIAL ROLE OF C1QB IN CHRONIC ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFS. | Mattia Rossi | ![]() |
![]() |
|||
441-OP | VALIDATION OF FLAVIN MONONUCLEOTIDE TO MONITOR QUALITY OF DONOR KIDNEYS DURING HYPOTHERMIC (OXYGENATED) MACHINE PERFUSION IN KIDNEY TRANSPLANTATION | Fenna Van De Leemkolk | ![]() |
![]() |
|||
442-OP | MONITORING OF MOLECULAR PROFILING OF REGULATORY T CELL BIOMARKERS BY USING NON-INVASIVE STRATEGIES TO PREDICT OUTCOME IN RENAL TRANSPLANTATION. | Angelica Canossi | ![]() |
![]() |
|||
443-OP | URINARY EXTRACELLULAR VESICLES AND VESICULAR CELL-FREE DNA AS POTENTIAL BIOMARKERS FOR KIDNEY ALLOGRAFT INJURY | Ivana Sedej | ![]() |
![]() |
|||
444-OP | NUCLEAR FACTOR OF ACTIVATED T CELLS AS POTENTIAL PHARMACODYNAMIC BIOMARKER FOR THE RISK OF ACUTE AND SUBCLINICAL REJECTION IN LIVER RECIPIENTS | Olga Millan | ![]() |
![]() |
|||
445-OP | CONNECTION OF BANK1, TOLERANCE, REGULATORY B CELLS, AND APOPTOSIS: PERSPECTIVES OF A REDUCTIONIST INVESTIGATION. | Ludmilla Le Berre | ![]() |
![]() |
|||
446-OP | IMPACT OF STEATOSIS AND COLD ISCHEMIA TIME ON MITOCHONDRIAL RESPIRATION IN HUMAN LIVER ALLOGRAFTS | Andras T. Meszaros | ![]() |
![]() |
|||
447-OP | APPLICATION OF THIN-FILM SOLID-PHASE MICROEXTRACTION TO BILE ANALYSIS - BILE FINGERPRINT AS A PROGNOSTIC MARKER DURING LIVER TRANSPLANTATION | Kamil Luczykowski | ![]() |
![]() |
|||
448-OP | VIABILITY ASSESSMENT USING THE "SIX GENE SIGNATURE" DURING LIVER PERFUSION | Rodrigo Figuerido | ![]() |
![]() |
|||
449-OP | ADVANTAGES OF PLASMATIC CXCL10 AS A PROGNOSTIC & DIAGNOSTIC BIOMARKER FOR THE RISK OF REJECTION AND SUBCLINICAL REJECTION IN KIDNEY TRANSPLANTATION. | Olga Millan | ![]() |
![]() |
|||
450-OP | MONITORING KIDNEY GRAFT INJURY BY MEASURING DONOR-DERIVED CELL FREE DNA (DD-CFDNA) | Emilio Rodrigo | ![]() |
![]() |
|||
451-OP | HUMAN CD81 EXTRACELLULAR VESICLES ARE RELEASED DURING NORMOTHERMIC MACHINE PERFUSION | Wouter Woud | ![]() |
![]() |
|||
452-OP | TRANSFORMING GROWTH FACTOR-?1 EXPRESSION IN RENAL TRANSPLANT URETER TISSUE AND POST-TRANSPLANT URETERAL STRICTURE | Emmy Hartog | ![]() |
![]() |
|||
454-OP | TREAT-TO-TARGET TRIAL OF CONTINUOUS SUBCUTANEOUS INSULIN-PUMP THERAPY IN NEW-ONSET DIABETES AFTER TRANSPLANTATION (SAPT-NODAT) | Amelie Kurnikowski | ![]() |
![]() |
|||
455-OP | SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITORS IN RENAL TRANSPLANT DIABETIC PATIENTS. SINGLE CENTER PILOT STUDY. | Claudia Muñoz Martínez | ![]() |
![]() |
|||
461-OP | PROPHYLACTIC DESENSITIZATION IN LUNG TRANSPLANT CANDIDATES WITH PRE-FORMED DONOR-SPECIFIC ANTIBODIES: 3-YEAR POST-TRANSPLANTATION OUTCOME. | Olivier Brugière | ![]() |
![]() |
|||
462-OP | LUNG TRANSPLANT RECIPIENTS DEVELOPING EARLY DSA WITHIN THE FIRST MONTH EXHIBIT A HIGHER FREQUENCY OF NAÏVE AND A LOWER FREQUENCY OF MEMORY B CELLS | Stella Christoph | ![]() |
![]() |
|||
463-OP | ALTERATION OF T LYMPHOCYTE SUBPOPULATIONS IN LUNG TRANSPLANTED PATIENT RECEIVING PROPHYLACTIC EXTRACORPOREAL PHOTOPHERESIS | Ara Cho | ![]() |
![]() |
|||
464-OP | PARTICLE FLOW RATE FROM THE AIRWAYS AS A MARKER FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) | Embla Bodén | ![]() |
![]() |
|||
466-OP | KAPOSI´S SARCOMA (KS) IN PEDIATRIC LIVER TRANSPLANTATION (LT) – 3 CLINICAL CASES | Catarina Cordeiro | ![]() |
![]() |
|||
469-OP | LONG TERM SURVIVAL AFTER CHORIOCARCINOMA TRANSMITTED BY LIVER GRAFT: A SUCCESSFUL REPORT IN PAEDIATRIC TRANSPLANTATION | Inês Pessanha | ![]() |
![]() |
|||
477-OP | CIRCULATING AND INTRAGRAFT DONOR(HLA)-SPECIFIC B CELLS DRIVE ANTIBODY-MEDIATED REJECTION IN HEART AND KIDNEY TRANSPLANT PATIENTS | Alba Torija | ![]() |
![]() |
|||
478-OP | ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFT IS ASSOCIATED WITH AN INCREASE IN DIFFERENTIATED CD28-CD8+ T CELLS IN THE PERIPHERAL BLOOD | Hoa Mai | ![]() |
![]() |
|||
479-OP | CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES PROTECT AGAINST CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Patricia Suàrez Fernández | ![]() |
![]() |
|||
480-OP | ANTIVIRAL TREATMENT PATTERNS FOR CYTOMEGALOVIRUS PREVENTION AMONG ADULT KIDNEY TRANSPLANT RECIPIENTS: A USRDS-MEDICARE LINKED DATABASE STUDY | Carlos Santos | ![]() |
![]() |
|||
481-OP | DONOR CYTOMEGALOVIRUS SEROPOSITIVITY CLUSTERS WITH RISK FACTORS FOR DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTATION, BUT DOES NOT DIRECTLY CONTRIBUTE | Richard Dumbill | ![]() |
![]() |
|||
482-OP | PREVENTION OF CYTOMEGALOVIRUS INFECTION BY EVEROLIMUS IN SEROPOSITIVE KIDNEY TRANSPLANT RECIPIENTS | Lionel Couzi | ![]() |
![]() |
|||
483-OP | VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY FOR PREVENTION OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS: A RANDOMIZED CONTROLLED TRIAL | Tomas Reischig | ![]() |
![]() |
|||
484-OP | INFECTION PATTERN IN EVEROLIMUS VERSUS MYCOPHENOLATE-BASED REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH RESULTS FROM THE TRANSFORM STUDY | Franco Citterio | ![]() |
![]() |
|||
485-OP | OUTCOME OF EBV NEGATIVE RECIPIENTS OF EBV POSITIVE DONOR ORGAN TRANSPLANT IN A SINGLE CENTRE | Caroline Dudreuilh | ![]() |
![]() |
|||
486-OP | TACROLIMUS METABOLISM RATE AND BK INFECTION IN RENAL TRANSPLANT PATIENTS | Dalvir Kular | ![]() |
![]() |
|||
487-OP | RELATIONSHIP BETWEEN CARBAPENEM-RESISTANT ENTEROBACTERALES CARRIAGE AND GUT MICROBIOME AFTER LIVER TRANSPLANTATION: A PROSPECTIVE COHORT STUDY | Matteo Rinaldi | ![]() |
![]() |
|||
488-OP | ASSOCIATION BETWEEN ACUTE GRAFT PYELONEPHRITIS AND KIDNEY GRAFT LOSS: A SINGLE-CENTER OBSERVATIONAL STUDY | Mehdi Maanaoui | ![]() |
![]() |
|||
489-OP | BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS: RESULT FROM A DANISH COHORT WITH NATIONWIDE FOLLOW-UP | Dina Leth Møller | ![]() |
![]() |
|||
490-OP | ENTEROCOCCAL INFECTIONS IN THE FIRST YEAR AFTER LIVER TRANSPLANTATION | Daniel Bräuner Rasmussen | ![]() |
![]() |
|||
491-OP | SUPERFICIAL SURGICAL SITE INFECTION AT HAND-PORT SITE AFTER HAND ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY FOR LIVING DONOR KIDNEY TRANSPLANTATION | Takahisa Hiramitsu | ![]() |
![]() |
|||
492-OP | CONTROLLED DONATION AFTER CIRCULATORY DEATH: IS THERE A RISK FACTOR OF CULTURE-POSITIVE PRESERVATION FLUID ON SOLID ORGANS FOR TRANSPLANTATION? | María Figueras | ![]() |
![]() |
|||
493-OP | THE "CRITICAL PATHWAY" FOR TISSUE DONATION: NEW DEFINITIONS FOR A COMMON AND SYSTEMATIC EUROPEAN APPROACH TO DECEASED DONOR TISSUE DONATION. | Alberto Sandiumenge | ![]() |
![]() |
|||
494-OP | HOW DO SPANISH TRANSPLANT COORDINATORS APPROACH RELATIVES FOR CONSENT TO INTENSIVE CARE FOR ORGAN DONATION? RESULTS OF AN EMPIRICAL STUDY | Rubén García-Sánchez | ![]() |
![]() |
|||
495-OP | ITALIAN SURVEY ON THE OPINIONS OF PROFESSIONALS FROM TRANSPLANT AND INTENSIVE CARE AREAS ABOUT COVID-19 AND SOLID ORGAN TRANSPLANTATION ACTIVITY | Federica Galiandro | ![]() |
![]() |
|||
496-OP | APPLICATION OF THEORY OF PLANNED BEHAVIOR ON ORGAN DONATION BEHAVIOR: A SYSTEMATIC REVIEW | Marzieh Latifi | ![]() |
![]() |
|||
497-OP | EUDONORGAN: A SUCCESSFUL TRAINING PROGRAM TO IMPROVE ORGAN DONATION KNOWLEDGE IN THE EUROPEAN UNION AND NEIGHBOURING COUNTRIES. | Patricia Peralta Lasso | ![]() |
![]() |
|||
498-OP | CONDITIONS THAT INFLUENCE FAMILY CONSENT FOR INTENSIVE CARE FOR ORGAN DONATION: THE PERSPECTIVE OF SPANISH TRANSPLANT COORDINATORS | Jorge S. López | ![]() |
![]() |
|||
499-OP | ENLIGHTENING YOUNG MINDS: A SMALL STEP IN THE CURRICULUM, A GIANT LEAP IN ORGAN DONATION - A SURVEY OF 996 RESPONDENTS ON ORGAN DONATION | Abdul Rahman Hakeem | ![]() |
![]() |
|||
500-OP | SEIZING THE POTENTIAL RISK OF TRANSMISSION OF OLIGODENDROGLIOMA TO RECIPIENTS | Serena Ammendola | ![]() |
![]() |
|||
501-OP | OUT-OF-HOSPITAL DONORS WITH IRREVERSIBLE CARDIAC ARREST IN RUSSIA: ONE OF THE PROMISING RECOURSE ACCORDING THE FIRST ST PETERSBURG EXPERIENCE | Andrey Skvortsov | ![]() |
![]() |
|||
502-OP | WHAT HAPPENS TO UNSPECIFIED KIDNEY DONOR CANDIDATES WHO CANNOT PROCEED TO DONATE: AN INDUCTIVE THEMATIC ANALYSIS FROM THE BOUND STUDY | Mira Zuchowski | ![]() |
![]() |
|||
503-OP | DECEASED DONOR TRANSPLANTATION DURING COVID TIMES - SUCCESS STORY FROM STATE IN INDIA. | Maria Gomez | ![]() |
![]() |
|||
504-OP | NEW TECHNOLOGIES APPLIED TO MASTER EDUCATION IN THE TIME OF COVID-19 | Chloe Balleste | ![]() |
![]() |
|||
505-OP | IMPACT OF THE SARS-COV-2 PANDEMIC ON TISSUE DONATION IN CATALONIA | Belen Garcés Jimeno | ![]() |
![]() |
|||
506-OP | EFFECTS OF THE SARS-COV2 PANDEMIC ON ORGAN OFFERS IN EUROPE | Federica Domini | ![]() |
![]() |
|||
508-OP | A NATIONAL SURVEY ON ENHANCED RECOVERY FOR RENAL TRANSPLANT RECIPIENTS: CURRENT PRACTICES AND TRENDS IN THE UNITED KINGDOM | Carrie Scuffell | ![]() |
![]() |
|||
509-OP | ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR RENAL TRANSPLANT RECIPIENTS: THE EARLY NEWCASTLE EXPERIENCE | Carrie Scuffell | ![]() |
![]() |
|||
510-OP | POSITIVE IMPACT OF ERAS PROGRAMME ON LIVING AND DECEASED DONOR RENAL TRANSPLANT RECIPIENTS DURING COVID PANDEMIC | Rachel Thomas | ![]() |
![]() |
|||
511-OP | FACTORS ASSOCIATED WITH PROLONGED LENGTH OF STAY FOLLOWING RENAL TRANSPLANTATION: A NURSE LED AUDIT | Leigh Whinham | ![]() |
![]() |
|||
514-OP | TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL. | Annelies De Weerd | ![]() |
![]() |
|||
515-OP | COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VS LCPT. | Gionata Spagnoletti | ![]() |
![]() |
|||
516-OP | OUTCOMES OF IL2-RA INDUCTION THERAPY IN STANDARD-RISK RENAL TRANSPLANT RECIPIENTS MAINTAINED ON TACROLIMUS - A META-ANALYSIS | Hatem Ali | ![]() |
![]() |
|||
519-OP | MESENCHYMAL STROMAL CELLS COMBINED WITH EVEROLIMUS PROMOTE T REG EXPANSION BUT DO NOT SYNERGIZE IN A RAT LIVER TRANSPLANT REJECTION MODEL | Morgan Vandermeulen | ![]() |
![]() |
|||
520-OP | EFFICIENT EXPANSION OF HUMAN GRANZYME B–EXPRESSING B CELLS WITH POTENT REGULATORY PROPERTIES | Hoa Mai | ![]() |
![]() |
|||
521-OP | GAMMA-DELTA T CELL THERAPY FOR THE TREATMENT OF POST-TRANSPLANT CMV INFECTION: PROOF OF CONCEPT | Gabriel Marseres | ![]() |
![]() |
|||
524-OP | CHARACTERIZATION OF MESENCHYMAL STEM CELL INDUCED REGULATORY B CELLS (MSC-INDUCED BREG) | Sergio G. Garcia | ![]() |
![]() |
|||
700-OP | MULTI-OMICS DATA INTEGRATION IN KIDNEY TRANSPLANTATION: THE HIDDEN PATHWAYS OF ANTIBODY-MEDIATED REJECTION | Claire Tinel | ![]() |
![]() |
|||
701-OP | DEEP PHENOTYPING OF HUMAN KIDNEY TRANSPLANT REJECTION USING SINGLE-CELL TRANSCRIPTOMICS | Baptiste Lamarthée | ![]() |
![]() |
|||
702-OP | REAL WORLD USE AND CLINICAL IMPACT OF EXTRACORPOREAL PHOTOPHERESIS IN HEART TRANSPLANT PATIENTS – RESULTS FROM A EUROPEAN MULTICENTER STUDY | Markus J. Barten | ![]() |
![]() |
|||
703-OP | EPLETS INCOMPATIBILITY AS A DETERMINANT IN EXPOSURE TO TACROLIMUS | Christian Córdoba Herrera | ![]() |
![]() |
|||
713-OP | DONATION AFTER CIRCULATORY DEATH (DCD) DONORS IN THE EMILIA-ROMAGNA REGION (ERR): OUR FIRST FORTY CASES | Carlo De Cillia | ![]() |
![]() |
|||
716-OP | POST-VACCINE IMMUNITY TO COVID-19 VACCINE IN END-STAGE RENAL DISEASE PATIENTS AND KIDNEY TRANSPLANT RECIPIENT | Magdalena Piotrowska | ![]() |
![]() |
|||
717-OP | ACUTE KIDNEY INJURY AFTER HEART TRANSPLANTATION: ROLE OF INTRAOPERATIVE MANAGEMENT | Veronica Moriconi | ![]() |
![]() |
|||
718-OP | METABOLIC OUTCOMES AFTER PANCREAS TRANSPLANTATION FROM DONORS AFTER CIRCULATORY DEATH - THE UK REGISTRY ANALYSIS | Jeevan Gopal | ![]() |
![]() |
|||
719-OP | PORTABLE GAMMA-CAMERA AS A USEFUL TOOL FOR BRAIN DEATH DIAGNOSIS | José Moya Sánchez | ![]() |
![]() |
|||
720-OP | SPECIFIC URINARY METABOLOMIC PROFILE IN SPONTANEOUS TOLERANT KIDNEY TRANSPLANTED RECIPIENTS | Luc Colas | ![]() |
![]() |
|||
721-OP | DESIGN OF STEADFAST STUDY EVALUATING TX200-TR101, A CHIMERIC ANTIGEN RECEPTOR T?REGULATORY CELL THERAPY FOR LIVING DONOR RENAL TRANSPLANT RECIPIENTS | Emily Culme-Seymour | ![]() |
![]() |
|||
722-OP | EARLY SAFETY OF SARS-COV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS | Michael Ou | ![]() |
![]() |
|||
723-OP | IDOTCOVID- INTERNATIONAL DATABASE ON ORGAN DONATION AND TRANSPLANTATION - COVID 19 | Pedro Ventura-Aguiar | ![]() |
![]() |
|||
724-OP | LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-COV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Brian Boyarsky | ![]() |
![]() |
|||
725-OP | SARS-COV 2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Renato Pascale | ![]() |
![]() |
|||
726-OP | PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE, UNCERTAINTY AND COPING STRATEGIES IN ORGAN TRANSPLANT RECIPIENTS DURING THE COVID PANDEMIC | Angus Hann | ![]() |
![]() |
|||
727-OP | MOTIVATION, EXPERIENCES, AND MENTAL HEALTH OUTCOMES OF UNSPECIFIED KIDNEY DONORS IN THE NETHERLANDS: A QUALITATIVE STUDY | Mathilde Pronk | ![]() |
![]() |
|||
728-OP | FIVE YEAR HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS PLUS REDUCED TACROLIMUS VS STANDARD TACROLIMUS AFTER LIVING-DONOR LIVER TRANSPLANTATION | Gonzalo Sapisochin | ![]() |
![]() |
|||
729-OP | PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Reshma Rana Magar | ![]() |
![]() |
Aug 29 - Sept 1, 2021 Milano
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|